M Katharine Holloway

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 2

Top Topics

Nlrp Inflammasome

Top Venues

Journal of medicinal chemistry

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

David Harrison, Andy Billinton, Mark G Bock, John R Doedens, Christopher A Gabel, M Katharine Holloway, Roderick A Porter, Valérie Reader, Jane Scanlon, Kenneth Schooley, Alan P Watt
Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders. Journal of medicinal chemistry (2023)
David Harrison, Mark G Bock, John R Doedens, Christopher A Gabel, M Katharine Holloway, Arwel Lewis, Jane Scanlon, Andrew Sharpe, Iain D Simpson, Pamela Smolak, Grant Wishart, Alan P Watt
Discovery and Optimization of Triazolopyrimidinone Derivatives as Selective NLRP3 Inflammasome Inhibitors. ACS medicinal chemistry letters 13 (8) (2022)